The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Complementary medicines (10)
- Regulatory compliance (33)
- Therapeutic goods regulation (33)
- Medicine safety (29)
- Prescription medicines (27)
- Vaping hub (19)
- Advertising (16)
- Legislation (15)
- Compliance and enforcement hub (13)
- Safety (12)
- Manufacturing (11)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Non-prescription medicines (9)
- Import and export (8)
- Labelling and packaging (8)
- Listed medicines (8)
- Medical devices safety (8)
- Medicinal cannabis hub (6)
- Over the counter (OTC) medicines (6)
- Alert/Advisory (5)
- COVID-19 vaccines (5)
- Scheduling (national classification system) (5)
- COVID-19 (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Weight loss products (3)
- Advisory bodies and committees (2)
- Clinical trials (2)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Fees and payments (1)
- Registered complementary medicines (1)
- Shortages (1)
- Sunscreens (1)
Search
10 result(s) found, displaying 1 to 10
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) which commenced on 27 September 2024.
-
Media releasesWe have issued an infringement notice to the New South Wales based company for the alleged supply of a complementary medicine that was missing a mandatory warning statement.
-
NoticesInformation for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
NewsThe Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.
-
Media releasesInfringement notices for $82,500 have been issued to Caruso’s Natural Health Pty Ltd, for an alleged failure to hold information or evidence to support therapeutic uses in relation to medicines.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
Media releasesWe issued an infringement notice for $13,320 to the New South Wales based company Marvel Health (Australia) Pty Ltd. This was for an alleged failure to comply with a notice to provide information about a complementary (listed) medicine.